Burke & Herbert Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

Burke & Herbert Bank & Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587K	Sell	3,085 -272	-8%	-$46.8K	0.15%	137
2026 Q1	$567K	Buy	3,357 +45	+1%	+$7.7K	0.16%	131
2025 Q4	$559K	Sell	3,312 -5,342	-62%	-$868K	0.15%	128
2025 Q3	$1.25M	Sell	8,654 -155	-2%	-$21.2K	0.27%	100
2025 Q2	$1.11M	Hold	8,809	–	–	0.25%	106
2025 Q1	$1.13M	Hold	8,809	–	–	0.27%	101
2024 Q4	$1.16M	Buy	8,809 +105	+1%	+$14.8K	0.28%	101
2024 Q3	$1.27M	Sell	8,704 -1,190	-12%	-$172K	0.29%	93
2024 Q2	$1.36M	Buy	+9,894	New	+$1.32M	0.33%	87

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Burke & Herbert Bank & Trust's IBB Position: Q2 2026 in Review

Burke & Herbert Bank & Trust reduced its iShares Biotechnology ETF (IBB) stake by 8.1% in Q2 2026, selling an estimated $46.8K and leaving 3,085 shares worth $587K. The position accounts for 0.15% of the portfolio, ranked #137.

Burke & Herbert Bank & Trust first reported a position in IBB in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.36M in Q2 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Burke & Herbert Bank & Trust held 3,085 shares of iShares Biotechnology ETF worth $587K as of Q2 2026.
Burke & Herbert Bank & Trust sold 272 iShares Biotechnology ETF shares in Q2 2026, an estimated $46.8K.
iShares Biotechnology ETF made up 0.15% of Burke & Herbert Bank & Trust's portfolio in Q2 2026, its #137 holding.
Burke & Herbert Bank & Trust first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 9 quarters since.
Burke & Herbert Bank & Trust's iShares Biotechnology ETF position peaked at $1.36M in Q2 2024.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Burke & Herbert Bank & Trust's 13F filing for Q2 2026, filed 7 Aug 2026.